Recent Advances in NAMPT Inhibitors: A Novel Immunotherapic Strategy.

作者: Ubaldina Galli , Giorgia Colombo , Cristina Travelli , Gian Cesare Tron , Armando A. Genazzani

DOI: 10.3389/FPHAR.2020.00656

关键词:

摘要: Nicotinamide adenine dinucleotide (NAD) is a cofactor of many enzymatic reactions as well being substrate for number NAD-consuming enzymes (e.g., PARPS, sirtuins, etc). NAD can be synthesized de novo starting from tryptophan, nicotinamide, nicotinic acid, or nicotinamide riboside the diet. On other hand, that liberated by salvaged to re-form NAD. In this former instance, phosphoribosyltransferase (NAMPT) bottleneck enzyme. cells in which salvage pathway predominant, NAMPT, therefore, represents an important controller intracellular concentrations, and consequence energy metabolism. It is, not surprising NAMPT over expressed tumoral cells, take advantage sustain growth rate tumor progression. This has led initiation numerous medicinal chemistry programs develop inhibitors context oncology. More recently, however, it been shown do solely target but also have effect on immune system. To add complexity, enzyme secreted extracellular space acts cytokine mainly through activation Toll like Receptor 4 (TLR4), although clarified yet if only receptor responsible its actions. While specific small molecules developed against form growing evidences possibility form. contribution, most recent will reviewed, together with key elements hypothesis targeting drawbacks so far encountered.

参考文章(119)
Xia Wang, Tian-Ying Xu, Xin-Zhu Liu, Sai-Long Zhang, Pei Wang, Zhi-Yong Li, Yun-Feng Guan, Shu-Na Wang, Guo-Qiang Dong, Shu Zhuo, Ying-Ying Le, Chun-Quan Sheng, Chao-Yu Miao, None, Discovery of Novel Inhibitors and Fluorescent Probe Targeting NAMPT Scientific Reports. ,vol. 5, pp. 12657- 12657 ,(2015) , 10.1038/SREP12657
Antonia Cagnetta, Irene Caffa, Chirag Acharya, Debora Soncini, Prakrati Acharya, Sophia Adamia, Ivana Pierri, Micaela Bergamaschi, Anna Garuti, Giulio Fraternali, Luca Mastracci, Alessandro Provenzani, Chiara Zucal, Gianluca Damonte, Annalisa Salis, Fabrizio Montecucco, Franco Patrone, Alberto Ballestrero, Santina Bruzzone, Marco Gobbi, Alessio Nencioni, Michele Cea, APO866 Increases Antitumor Activity of Cyclosporin-A by Inducing Mitochondrial and Endoplasmic Reticulum Stress in Leukemia Cells Clinical Cancer Research. ,vol. 21, pp. 3934- 3945 ,(2015) , 10.1158/1078-0432.CCR-14-3023
Mara Gallí, Frédéric Van Gool, Anthony Rongvaux, Fabienne Andris, Oberdan Leo, The Nicotinamide Phosphoribosyltransferase: A Molecular Link between Metabolism, Inflammation, and Cancer Cancer Research. ,vol. 70, pp. 8- 11 ,(2010) , 10.1158/0008-5472.CAN-09-2465
Deepak Sampath, Tanja S. Zabka, Dinah L. Misner, Thomas O’Brien, Peter S. Dragovich, Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer Pharmacology & Therapeutics. ,vol. 151, pp. 16- 31 ,(2015) , 10.1016/J.PHARMTHERA.2015.02.004
Kyle Holen, Leonard B. Saltz, Ellen Hollywood, Konrad Burk, Axel-Rainer Hanauske, The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor Investigational New Drugs. ,vol. 26, pp. 45- 51 ,(2008) , 10.1007/S10637-007-9083-2
Javier R. Revollo, Antje Körner, Kathryn F. Mills, Akiko Satoh, Tao Wang, Antje Garten, Biplab Dasgupta, Yo Sasaki, Cynthia Wolberger, R. Reid Townsend, Jeffrey Milbrandt, Wieland Kiess, Shin-ichiro Imai, Nampt/PBEF/visfatin regulates insulin secretion in β cells as a systemic NAD biosynthetic enzyme Cell Metabolism. ,vol. 6, pp. 363- 375 ,(2007) , 10.1016/J.CMET.2007.09.003
Tie-Qiang Bi, Xiang-Ming Che, Xin-Hua Liao, Dan-Jie Zhang, Hou-Long Long, Hai-Jun Li, Wei Zhao, Overexpression of Nampt in gastric cancer and chemopotentiating effects of the Nampt inhibitor FK866 in combination with fluorouracil. Oncology Reports. ,vol. 26, pp. 1251- 1257 ,(2011) , 10.3892/OR.2011.1378
Z Moore, G Chakrabarti, X Luo, A Ali, Z Hu, FJ Fattah, R Vemireddy, RJ DeBerardinis, RA Brekken, DA Boothman, None, NAMPT inhibition sensitizes pancreatic adenocarcinoma cells to tumor-selective, PAR-independent metabolic catastrophe and cell death induced by β-lapachone. Cell Death and Disease. ,vol. 6, ,(2015) , 10.1038/CDDIS.2014.564
Michele Cea, Debora Soncini, Floriana Fruscione, Lizzia Raffaghello, Anna Garuti, Laura Emionite, Eva Moran, Mirko Magnone, Gabriele Zoppoli, Daniele Reverberi, Irene Caffa, Annalisa Salis, Antonia Cagnetta, Micaela Bergamaschi, Salvatore Casciaro, Ivana Pierri, Gianluca Damonte, Filippo Ansaldi, Marco Gobbi, Vito Pistoia, Alberto Ballestrero, Franco Patrone, Santina Bruzzone, Alessio Nencioni, Synergistic Interactions between HDAC and Sirtuin Inhibitors in Human Leukemia Cells PLoS ONE. ,vol. 6, pp. e22739- 366 ,(2011) , 10.1371/JOURNAL.PONE.0022739
Frédéric Van Gool, Mara Gallí, Cyril Gueydan, Véronique Kruys, Pierre-Paul Prevot, Antonio Bedalov, Raul Mostoslavsky, Frederick W Alt, Thibaut De Smedt, Oberdan Leo, Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner Nature Medicine. ,vol. 15, pp. 206- 210 ,(2009) , 10.1038/NM.1906